risedronate sodium
Generic: risedronate sodium
Labeler: sun pharmaceutical industires inc.Drug Facts
Product Profile
Brand Name
risedronate sodium
Generic Name
risedronate sodium
Labeler
sun pharmaceutical industires inc.
Dosage Form
TABLET, DELAYED RELEASE
Routes
Active Ingredients
risedronate sodium 35 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
63304-440
Product ID
63304-440_d97c9e6a-01e9-46ae-9088-0ca86b4eb842
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA203925
Listing Expiration
2026-12-31
Marketing Start
2019-07-10
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
63304440
Hyphenated Format
63304-440
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
risedronate sodium (source: ndc)
Generic Name
risedronate sodium (source: ndc)
Application Number
ANDA203925 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 35 mg/1
Packaging
- 1 DOSE PACK in 1 CARTON (63304-440-09) / 4 TABLET, DELAYED RELEASE in 1 DOSE PACK (63304-440-11)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "d97c9e6a-01e9-46ae-9088-0ca86b4eb842", "openfda": {"unii": ["OFG5EXG60L"], "rxcui": ["1020064", "1020065"], "spl_set_id": ["1d9e520b-2fa6-4603-b397-f0fc24fae775"], "manufacturer_name": ["Sun Pharmaceutical Industires Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 DOSE PACK in 1 CARTON (63304-440-09) / 4 TABLET, DELAYED RELEASE in 1 DOSE PACK (63304-440-11)", "package_ndc": "63304-440-09", "marketing_start_date": "20190710"}], "brand_name": "RISEDRONATE SODIUM", "product_id": "63304-440_d97c9e6a-01e9-46ae-9088-0ca86b4eb842", "dosage_form": "TABLET, DELAYED RELEASE", "pharm_class": ["Bisphosphonate [EPC]", "Diphosphonates [CS]"], "product_ndc": "63304-440", "generic_name": "RISEDRONATE SODIUM", "labeler_name": "Sun Pharmaceutical Industires Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "RISEDRONATE SODIUM", "active_ingredients": [{"name": "RISEDRONATE SODIUM", "strength": "35 mg/1"}], "application_number": "ANDA203925", "marketing_category": "ANDA", "marketing_start_date": "20190710", "listing_expiration_date": "20261231"}